期刊文献+

代谢综合征患者发生胆囊结石危险性研究 被引量:2

Study on Risk of Cholecystolithiasis in Patients with Metabolic Syndrome
下载PDF
导出
摘要 目的研究代谢综合征(MS)患者发生胆囊结石的危险性。方法选取我院2006年4月至2010年1月期间的体检者共4 076例,排除过量饮酒、乙肝标志物阳性、严重感染及MS资料不全者,共2 830例纳入研究,其中1 367例在1~3年后再次体检。记录身高、体重、血压、血脂及空腹血糖。结果 BMI≥25 kg/m^2、血压≥140/90 mm Hg、合并MS中2个组分者发生胆囊结石的OR值分别为1.458(95%CI为1.124~1.892,P=0.004)、1.975(95%CI为1.418~2.752,P=0.000)和1.751(95%CI为1.256~2.439,P=0.001)。结论代谢紊乱时发生胆囊结石的风险增加。 Objective To study the risk ofcholecystolithiasis in patients with metabolic syndrome (MS). Methods 4 076 people with physical examination in our hospital flom April 2006 to January 2010 were selected, and 2 830 people were enrolled excluding those with excessive drinking, positive hepatitis B viruses, severe infection and incomplete MS data. 1 367 cases received physical examination again after 1 to 3 years. The height, weight, blood pressure, blood fat and fasting blood glucose were recorded. Results The OR values of cholecystolithiasis in patients with BMI ≥25 kg/m2, blood pressure ≥ 140/90 mm Hg and two components of MS were respectively 1.458 (95%CI 1.124 - 1.892, P= 0.004), 1.975 (95%CI 1.418 - 2.752, P= 0.000) and 1.751 (95%CI 1.256 - 2.439, P= 0.001). Conclusions The risk of cholecystolithiasis increases when metabolism has disorders.
作者 刘瑛 张弛
出处 《临床医学工程》 2017年第11期1635-1636,共2页 Clinical Medicine & Engineering
关键词 代谢综合征 胆囊结石 胰岛素抵抗 Metabolic syndrome Cholecystolithiasis Insulin resistance
  • 相关文献

参考文献2

二级参考文献46

  • 1Archard C, Thiers J. Le virlisme pilaire et son association a l'insuffisance glycolytique (diabe'te des femmes a barb). Bull Acad Natl Med 1921; 86: 51-64.
  • 2Vague J. The degree of masculine differentiation of obesities: A factor-determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956; 4: 20-34.
  • 3Welborn TA, Breckenridge A, Rubinstein AH, Dollery CT, Fraser TR. Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet 1966; 1: 1336-1337.
  • 4Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
  • 5Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. Jama 2002; 287: 356-359.
  • 6Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003; 26: 575-581.
  • 7Aguilar-Salinas CA, Rojas R, Gomez-Perez FJ, Valles V, Rios-Torres JM, Franco A, Olaiz G, Rull JA, Sepulveda J. Analysis of the agreement between the World Health Organization criteria and the National Cholesterol Education Program-III definition of the metabolic syndrome: Results from a population-based survey. Diabetes Care 2003; 26: 1635.
  • 8National Institutes of Health Consensus Development Conference Statement on Gallstones and Laparoscopic Cholecystectomy. Am J Surg 1993; 165: 390-398.
  • 9Russo MW, Wei JT, Thiny MT, Gangarosa LM, Brown A, Ringel Y, Shaheen NJ, Sandler RS. Digestive and liver diseases statistics, 2004. Gastroenterology 2004; 126: 1448-1453.
  • 10Diehl AK. Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am 1991; 20: 1-19.

共引文献3085

同被引文献13

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部